The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Do Older Men Benefit From Curative Therapy of Localized Prostate Cancer?
Abstract
Purpose: Prior decision-analytic models are based on outdated or suboptimal efficacy, patient preference, and comorbidity data. We estimated life expectancy (LE) and quality-adjusted life expectancy (QALE) associated with available treatments for localized prostate cancer in men aged ≥ 65 years, adjusting for Gleason score, patient preferences, and comorbidity. Methods: We evaluated three treatments, using a decision-analytic Markov model: radical prostatectomy (RP), external beam radiotherapy (EBRT), and watchful waiting (WW). Rates of treatment complications and pretreatment incontinence and impotence were derived from published studies. We estimated treatment efficacy using three data sources: cancer registry cohort data, pooled case series, and modern radiotherapy studies. Utilities were obtained from 141 prostate cancer patients and from published studies. Results: For men with well-differentiated tumors and few comorbidities, potentially curative therapy (RP or EBRT) prolonged LE up to age 75 years but did not improve QALE at any age. For moderately differentiated cancers, potentially curative therapy resulted in LE and QALE gains up to age 75 years. For poorly differentiated disease, potentially curative therapy resulted in LE and QALE gains up to age 80 years. Benefits of potentially curative therapy were restricted to men with no worse than mild comorbidity. When cohort and pooled case series data were used, RP was preferred over EBRT in all groups but was comparable to modern radiotherapy. Conclusion: Potentially curative therapy results in significantly improved LE and QALE for older men with few comorbidities and moderately or poorly differentiated localized prostate cancer. Age should not be a barrier to treatment in this group.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Patient and Community Preferences for Outcomes in Prostate Cancer: Implications for Clinical Policy
Krahn, M., Ritvo, P., Irvine, J., Tomlinson, G., Bremner, K. E., Bezjak, A., Trachtenberg, J., & Naglie, G. (2003) · Medical Care · doi:10.1097/00005650-200301000-00017 · Cited by 119
Self-citation
Cited by
Impact of Age at Diagnosis on Prostate Cancer Treatment and Survival
Bechis, S. K., Carroll, P. R., & Cooperberg, M. R. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.2075 · Cited by 392
Droz, J., Balducci, L., Bolla, M., Emberton, M., Fitzpatrick, J. M., Joniau, S., Kattan, M. W., Monfardini, S., Moul, J. W., Naeim, A., et al. (2010) · BJU International · doi:10.1111/j.1464-410x.2010.09334.x · Cited by 258
Hayes, J. H., Ollendorf, D. A., Pearson, S. D., Barry, M. J., Kantoff, P. W., Stewart, S. T., Bhatnagar, V., Sweeney, C. J., Stahl, J. E., & McMahon, P. M. (2010) · JAMA · doi:10.1001/jama.2010.1720 · Cited by 257
Alibhai, S. M. H., Gogov, S., & Allibhai, Z. (2006) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2006.06.006 · Cited by 173
“[15] Alibhai SMH, Naglie G, Nam R, Trachtenberg J, Krahn MD.”
BackgroundSelf-citation
Metadata
- Authors
- Alibhai, S. M. H., Naglie, G., Nam, R., Trachtenberg, J., & Krahn, M. D.
- Venue
- Journal of Clinical Oncology
- Published
- 2003-09-01
- Volume
- 21
- Issue
- 17
- Pages
- 3318-3327
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2056553154
- Cited by
- 163
- References
- 1
- FWCI
- 7.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Do Older Men Benefit From Curative Therapy of Localized Prostate Cancer? https://app.cochat.ai/papers/10.1200/jco.2003.09.034
- The paper
- Alibhai, S. M. H., Naglie, G., Nam, R., Trachtenberg, J., & Krahn, M. D. (2003). Do Older Men Benefit From Curative Therapy of Localized Prostate Cancer? Journal of Clinical Oncology. https://doi.org/10.1200/jco.2003.09.034
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.